Chargement en cours...

Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses

Chronic infection with hepatitis B virus (HBV) increases the risk of developing fibrosis, cirrhosis or hepatocellular carcinoma. Current therapies are limited to type‐I interferons and/or nucleos(t)ide analogues; however, these are only partially effective. The development of novel anti‐HBV agents f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Sci
Auteurs principaux: Nishitsuji, Hironori, Harada, Keisuke, Ujino, Saneyuki, Zhang, Jing, Kohara, Michinori, Sugiyama, Masaya, Mizokami, Masashi, Shimotohno, Kunitada
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5765299/
https://ncbi.nlm.nih.gov/pubmed/29121422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13440
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!